Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.

about

Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.

Item

http://www.wikidata.org/entity/Q49964009

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic impact of CD200 and ...... mphoblastic leukemia patients.

@en

Prognostic impact of CD200 and ...... mphoblastic leukemia patients.

@nl

type

Item

label

Prognostic impact of CD200 and ...... mphoblastic leukemia patients.

@en

Prognostic impact of CD200 and ...... mphoblastic leukemia patients.

@nl

prefLabel

Prognostic impact of CD200 and ...... mphoblastic leukemia patients.

@en

Prognostic impact of CD200 and ...... mphoblastic leukemia patients.

@nl

P1476

Prognostic impact of CD200 and ...... ymphoblastic leukemia patients

@en

P2093

Emad Azmy

http://www.w3.org/2001/XMLSchema#string

Kadry El-Bakry

http://www.w3.org/2001/XMLSchema#string

Lobna Ibrahim

http://www.w3.org/2001/XMLSchema#string

Sherin Abdel Aziz

http://www.w3.org/2001/XMLSchema#string

P2860

The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans

Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia

Biology and clinical impact of human natural killer cells.

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy

Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults.

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

A Simple, Versatile Antibody-Based Barcoding Method for Flow Cytometry.

P304

275-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08880018.2017.1363836

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salah Aref

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29144828

http://www.w3.org/2001/XMLSchema#string